A
$ Value
$0
Shares
3,205
Price
$0
Filed
Sep 15
Insider
Name
Chopra Daveen
Title
CVP, TMTT & Surgical
CIK
0001740963
Roles
Officer
Transaction Details
Transaction Date
2025-09-11
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
34,201
Footnotes
These restricted stock units were granted on September 11, 2025 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments.
Filing Info
Chopra Daveen's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-12-11 | EW | ▼ | $169K |
| 2025-09-11 | EW | A | $0 |
| 2025-08-25 | EW | ▼ | $205K |
| 2025-05-22 | EW | ▼ | $113K |
| 2025-05-11 | EW | F | $43K |
| 2025-05-08 | EW | A | $0 |
| 2025-05-08 | EW | A | $0 |
| 2025-05-08 | EW | A | $0 |
| 2025-05-07 | EW | F | $47K |
| 2025-05-04 | EW | F | $22K |
Other Insiders at EW (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
BOBO DONALD E JR
CVP,Strategy/Corp Development
|
— | $4.8M | 2026-04-02 |
|
Ullem Scott B.
CVP, Chief Financial Officer
|
— | $2.1M | 2026-04-09 |
|
Zovighian Bernard J
CEO
|
— | $1.7M | 2026-02-13 |
|
Lippis Daniel J.
CVP, TAVR
|
— | $170K | 2026-04-06 |
|
Dahl Andrew M.
SVP, Corporate Controller
|
— | — | 2026-02-22 |